Head-to-head · WeighScore
AgelessRx vs Aquivia Health
By GLP-1 ScorecardUpdated
Score comparison
AgelessRx has the higher recorded score — 84.3/100 to 74.6/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | Aquivia Health |
|---|---|---|
| WeighScore | 84.3/100 | 74.6/100 |
| Grade | B | C |
| Site position | #17 | #64 |
| Semaglutide | Not verified (current medication-specific quote required) | $149/mo |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | $179/mo |
| Coverage | Advertises US service; confirm treatment-specific state availability | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Not confirmed |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
Site position #64 · C
Strengths
- Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
- Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
- Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
- Both compounded and branded GLP-1s offered side by side — unusual for a compounded provider
- Self-pay model with no insurance required and no separate consultation fee
What to consider
- No public list of states served — you must complete intake to learn if your state qualifies
- No named 503A compounding pharmacy partner, limiting licensure verification
- No LegitScript, PCAB, or BBB trust badges visible
- Brand confusion: site schema names 'CatalystMD' while the customer-facing brand is Aquivia Health
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.